The Royal Melbourne Hospital is a world renowned institution, providing outstanding care and treatment and improving health outcomes through a comprehensive medical research program and training of future health professionals.
Units of the Doherty Institute from the Royal Melbourne Hospital:
The Victorian Infectious Diseases Reference Laboratory (VIDRL) is Australia’s leading infectious diseases reference laboratory. Formally designated as a Victorian public health laboratory in 1992, VIDRL provides the Victorian Department of Health with virology and mycobacteria public health reference laboratory services including surveillance, outbreak investigations, reference testing and research, and also performs diagnostic testing for hospitals. In addition, VIDRL has national reference laboratory designations to the Australian Department of Health for polio and enteroviruses, measles, viral haemorrhagic fevers and smallpox. VIDRL is also the designated base for the World Health Organisation (WHO) Polio Regional Reference Laboratory for the Western Pacific Region, WHO Measles Regional Reference Laboratory for the Western Pacific Region, WHO Hepatitis B Regional Reference Laboratory for the Western Pacific Region, WHO National Influenza Centre, WHO Collaborating Centre for Reference and Research on Influenza (see below), WHO Collaborating Centre for Mycobacterium Ulcerans and WHO Collaborating Centre for Viral Hepatitis.
The WHO Collaborating Centre for Reference and Research on Influenza is part of the WHO Global Influenza Surveillance and Response System. The network was established in 1952 to monitor the frequent changes in influenza and reduce the impact of its viruses. Together with the WHO Collaborating Centres in Atlanta, Beijing, London and Tokyo, the Centre is responsible for analysing influenza viruses currently circulating in the human population across the globe. This information is used by the WHO to make recommendations on appropriate viruses to be included in annual seasonal influenza vaccines for the northern and southern hemispheres. The Centre also undertakes research, training and regional capacity building activities related to influenza.
The WHO Collaborating Centre for Viral Hepatitis (the Centre), Victorian Infectious Diseases Reference Laboratory (VIDRL) at The Peter Doherty Institute for Infection and Immunity (Doherty Institute) was designated on 1 June 2015 as one of only five Collaborating Centres for Viral Hepatitis globally. The Centre performs a broad range of activities supporting national and global control of viral hepatitis, including basic research and reference virology, surveillance, treatment and prevention initiatives, and training and regional capacity building. In addition, the Centre is active in public health policy development and assists the WHO in implementing the Global Health Sector Strategy on Viral Hepatitis.
The Victorian Infectious Diseases Service (VIDS) provides a full range of inpatient and outpatient infectious diseases services, with a special focus on travel-related and tropical infections, HIV, hepatitis, tuberculosis and healthcare associated infections. Established in 1996 at the Royal Melbourne Hospital following the closure of the Fairfield Infectious Diseases Hospital, today the VIDS team includes infectious disease physicians, nurses, pharmacists, epidemiologists, information technology staff and allied health professionals with an established record of clinical research, strong links to public health and a commitment to evidence-based practices.
VIDS also includes the Victorian Tuberculosis Program – a multi-disciplinary team providing statewide public health services relating to tuberculosis. Some members of the University’s Department of Medicine also sit within VIDS at the Doherty Institute, with a focus on malaria and refugee health.
Established in 2002, the aim of the Victorian Healthcare Associated Infection Surveillance System (VICNISS) is to reduce the number of infections acquired in acute care public and private Victorian hospitals by monitoring and reporting infection rates. The team comprises of infection control consultants, infectious disease physicians, and others with epidemiological and bio statistical skills who collect, analyse and report data on healthcare associated infections.
The Royal Melbourne Hospital Guidance Group consists of a multi-disciplinary team of clinicians, epidemiologists, software developers, data architects and UX/UI designers who are continuously striving to develop, maintain and enhance innovative tools to support antimicrobial stewardship (AMS) initiatives. The Guidance Group is a key partner of the National Centre for Antimicrobial Stewardship (NCAS) and collaborator with the University of Melbourne Centre for Digital Health Transformation.